Acusensus Appendix 4E and FY25 Annual Report
| Stock | Acusensus Ltd (ACE.ASX) |
|---|---|
| Release Time | 26 Aug 2025, 8:11 a.m. |
| Price Sensitive | Yes |
Acusensus Appendix 4E and FY25 Annual Report
- Revenue grew from $49.6 million FY24 to $59.4 million FY25
- No debt, positive cash reserves ($21.5 million)
- 17 long-term recurring contracts, 260+ employees globally
Acusensus Limited, a leading provider of AI-enabled road safety solutions, has released its Appendix 4E and FY25 Annual Report, highlighting a period of remarkable strategic achievement and financial performance. The company's revenue grew by 19.6% to $59.4 million in FY25, up from $49.6 million in the previous year. Acusensus maintained a robust balance sheet, with no debt and positive cash reserves of $21.5 million. The company also secured 17 long-term recurring contracts and expanded its global footprint, with 260+ employees across the world. Key strategic highlights include the Western Australia Multi-function contract, Queensland expansion, and significant contract wins in New Zealand, the United States, and the United Kingdom. Acusensus also made progress in innovative areas like road worker safety and impaired driving detection. The board and management team remain committed to delivering sustainable shareholder value and continuing to drive global road safety improvements.
Acusensus reported revenue of $59.4 million for the financial year ended 30 June 2025, a 19.6% increase from the previous year. The company achieved a gross profit margin of 44.8% and Adjusted EBITDA of $5.7 million.
Acusensus is well-positioned for continued success, with significant contract wins and program expansions in Australia, New Zealand, the United States, and the United Kingdom. The company remains committed to further investment in business development, product innovation, and operational capabilities to meet the evolving needs of its global customers.